Julander JG - Search Results

1

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections.

Furuta Y, Takahashi K, Shiraki K, Sakamoto K, Smee DF, Barnard DL, Gowen BB, Julander JG, Morrey JD. Furuta Y, et al. Among authors: julander jg. Antiviral Res. 2009 Jun;82(3):95-102. doi: 10.1016/j.antiviral.2009.02.198. Epub 2009 Mar 6. Antiviral Res. 2009. PMID: 19428599 Free PMC article. Review.

2

Structural constraints link differences in neutralization potency of human anti-Eastern equine encephalitis virus monoclonal antibodies.

Williamson LE, Bandyopadhyay A, Bailey K, Sirohi D, Klose T, Julander JG, Kuhn RJ, Crowe JE Jr. Williamson LE, et al. Among authors: julander jg. Proc Natl Acad Sci U S A. 2023 Mar 28;120(13):e2213690120. doi: 10.1073/pnas.2213690120. Epub 2023 Mar 24. Proc Natl Acad Sci U S A. 2023. PMID: 36961925 Free PMC article.

3

Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus.

Julander JG, Sidwell RW, Morrey JD. Julander JG, et al. Antiviral Res. 2002 Jul;55(1):27-40. doi: 10.1016/s0166-3542(01)00223-6. Antiviral Res. 2002. PMID: 12076749

4

Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus.

Julander JG, Colonno RJ, Sidwell RW, Morrey JD. Julander JG, et al. Antiviral Res. 2003 Aug;59(3):155-61. doi: 10.1016/s0166-3542(03)00109-8. Antiviral Res. 2003. PMID: 12927305

5

Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model.

Iyer RP, Roland A, Jin Y, Mounir S, Korba B, Julander JG, Morrey JD. Iyer RP, et al. Among authors: julander jg. Antimicrob Agents Chemother. 2004 Jun;48(6):2318-20. doi: 10.1128/AAC.48.6.2318-2320.2004. Antimicrob Agents Chemother. 2004. PMID: 15155244 Free PMC article.

6

Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models.

Morrey JD, Day CW, Julander JG, Blatt LM, Smee DF, Sidwell RW. Morrey JD, et al. Among authors: julander jg. Antivir Chem Chemother. 2004 Mar;15(2):101-9. doi: 10.1177/095632020401500202. Antivir Chem Chemother. 2004. PMID: 15185728 Free article.

7

Modeling hamsters for evaluating West Nile virus therapies.

Morrey JD, Day CW, Julander JG, Olsen AL, Sidwell RW, Cheney CD, Blatt LM. Morrey JD, et al. Among authors: julander jg. Antiviral Res. 2004 Jul;63(1):41-50. doi: 10.1016/j.antiviral.2004.02.005. Antiviral Res. 2004. PMID: 15196819

8

Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival.

Julander JG, Winger QA, Olsen AL, Day CW, Sidwell RW, Morrey JD. Julander JG, et al. Antiviral Res. 2005 Feb;65(2):79-85. doi: 10.1016/j.antiviral.2004.10.005. Antiviral Res. 2005. PMID: 15708634

9

Error-prone replication of West Nile virus caused by ribavirin.

Day CW, Smee DF, Julander JG, Yamshchikov VF, Sidwell RW, Morrey JD. Day CW, et al. Among authors: julander jg. Antiviral Res. 2005 Jul;67(1):38-45. doi: 10.1016/j.antiviral.2005.04.002. Antiviral Res. 2005. PMID: 15919121

10

West Nile virus infection of the placenta.

Julander JG, Winger QA, Rickords LF, Shi PY, Tilgner M, Binduga-Gajewska I, Sidwell RW, Morrey JD. Julander JG, et al. Virology. 2006 Mar 30;347(1):175-82. doi: 10.1016/j.virol.2005.11.040. Epub 2006 Jan 9. Virology. 2006. PMID: 16406457 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page